Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
Lilly Earnings Beat
Description
Eli Lilly beat earnings and raised outlook as demand for key drugs surged.
More from User
01:02
Karp Sounds Reg Alarm
Benzinga
01:02
SEC Kills PDT
Benzinga
00:56
Walmart Adds Subway Delivery
Benzinga
00:55
GLP-1s Fuel Return Surge
Benzinga
00:52
Hegseth Firm On Anthropic
Benzinga
01:05
Lululemon Falls On Outlook
Benzinga
Related Videos
00:48
Eli Lilly accused of bribing doctors to prescribe Mounjaro and other drugs
Straight Arrow News
00:39
Eli Lilly Misses Q3 Targets, Lowers Full-Year Outlook on Weak Zepbound, Mounjaro Sales
Benzinga
03:24
Eli Lilly Q3 Earnings: Mounjaro Sales More Than Double, Takes $2.98 Billion Hit To Profit, Cuts Annual Outlook, Stock Tanks
Benzinga
03:06
Lilly Cuts Prices for Cash Buyers of Weight-Loss Drug Zepbound
Bloomberg
00:54
Eli Lilly Launches Multi-Dose Zepbound Pen to Drive Obesity Drug Growth
Cheddar News
00:35
Eli Lilly Slashes Zepbound Prices to Boost Accessibility for Patients and Combat Counterfeit Drugs
Benzinga